Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Orthofix Medical (OFIX) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Orthofix Medical (OFIX) over the last 16 years, with Q3 2025 value amounting to 8.29%.

  • Orthofix Medical's EBIT Margin rose 13200.0% to 8.29% in Q3 2025 from the same period last year, while for Sep 2025 it was 11.42%, marking a year-over-year increase of 2400.0%. This contributed to the annual value of 10.58% for FY2024, which is 80500.0% up from last year.
  • According to the latest figures from Q3 2025, Orthofix Medical's EBIT Margin is 8.29%, which was up 13200.0% from 7.88% recorded in Q2 2025.
  • Over the past 5 years, Orthofix Medical's EBIT Margin peaked at 5.62% during Q2 2022, and registered a low of 34.08% during Q1 2023.
  • For the 5-year period, Orthofix Medical's EBIT Margin averaged around 9.42%, with its median value being 8.29% (2025).
  • In the last 5 years, Orthofix Medical's EBIT Margin skyrocketed by 322300bps in 2021 and then crashed by -311900bps in 2023.
  • Orthofix Medical's EBIT Margin (Quarter) stood at 7.48% in 2021, then fell by -21bps to 9.04% in 2022, then fell by -1bps to 9.14% in 2023, then soared by 42bps to 5.32% in 2024, then crashed by -56bps to 8.29% in 2025.
  • Its EBIT Margin stands at 8.29% for Q3 2025, versus 7.88% for Q2 2025 and 25.24% for Q1 2025.